
北美脑积水分流市场预测至 2028 年 – COVID-19 影响和区域分析 – 按年龄组(儿童和成人)、类型(脑室-腹膜、脑室-心房、脑室-胸膜和腰腹-腹膜)、产品(脑积水瓣膜、脑积水导管、神经导航系统等)和最终用户(医院、门诊手术中心等)
No. of Pages: 127 | Report Code: BMIRE00027769 | Category: Life Sciences
No. of Pages: 127 | Report Code: BMIRE00027769 | Category: Life Sciences
大脑和脊髓中的脑脊液 (CSF) 可保护中枢神经系统免受损伤和感染。过量的脑脊液在脑腔内积聚会增加颅内压,从而导致脑积水。这种情况可能进一步导致巨头畸形和认知功能障碍。脑积水在儿童和婴儿中比在成人中更常见。这种疾病在60岁及以上的人群中也很流行。据脑积水协会称,这种疾病影响着超过 100 万美国人。此外,在美国,脑积水的发病率为每 770 名婴儿中就有 1 人患有脑积水。脑积水的治疗方法高度关注通过称为分流器的医疗设备来管理脑脊液。分流系统从大脑中去除多余的脑脊液,并将其转移到身体的其他部位,并在其中作为循环过程的一部分被吸收。因此,脑积水的高发病率推动了对脑积水分流器的需求,从而推动了北美脑积水分流器市场的增长。
北美脑积水分流器市场已细分为美国、加拿大和墨西哥。美国是该地区市场的主要贡献者。该地区的市场增长归因于随着神经系统疾病发病率的增加以及发达的医疗保健结构的可用性而引起的健康问题的增加。据脑积水组织称,脑积水是一种神经系统疾病,在美国,每 770 名新生儿中就有 1 人患有脑积水,每 100 名老年人中就有 1 人患有脑积水。此外,主要医疗公司对神经外科设备研发的高额投资,以减轻脑积水的社会经济负担,促进了北美市场的增长。
北美脑积水分流器市场根据年龄组、类型、产品、最终用户和国家/地区进行细分.
根据年龄组,北美脑积水分流器市场分为儿童和成人。预计到2022年,儿科细分市场将占据更大的市场份额。
从类型来看,北美脑积水分流器市场分为脑室-腹膜、脑室-心房、脑室胸膜和腰腹膜。到 2022 年,脑室-腹膜细分市场将占据最大的市场份额。
北美脑积水分流器市场按产品细分为脑积水瓣膜、脑积水导管、神经导航系统, 和别的。脑积水瓣膜预计将在 2022 年占据市场主导地位。
根据最终用户,北美脑积水分流器市场分为医院、门诊手术中心等。到 2022 年,医院细分市场可能会占据市场主导地位。
就国家而言,北美脑积水分流器市场分为美国、加拿大和墨西哥。预计美国将在 2022 年占据市场主导地位。
B.布劳恩·梅尔松根股份公司 (CHRISTOPH MIETHKE GMBH & CO. KG);索菲萨; HpBio Proteses, Inc. ; Integra生命科学控股公司;钟化医疗株式会社;美敦力;内特斯医疗公司;和 Spiegelberg GmbH &两合公司。是北美脑积水分流器市场的领先公司。
Strategic insights for North America Hydrocephalus Shunts involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 122.61 Million |
Market Size by 2028 | US$ 150.64 Million |
Global CAGR (2022 - 2028) | 3.5% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 年龄组
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Hydrocephalus Shunts refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Hydrocephalus Shunts Market is valued at US$ 122.61 Million in 2022, it is projected to reach US$ 150.64 Million by 2028.
As per our report North America Hydrocephalus Shunts Market, the market size is valued at US$ 122.61 Million in 2022, projecting it to reach US$ 150.64 Million by 2028. This translates to a CAGR of approximately 3.5% during the forecast period.
The North America Hydrocephalus Shunts Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Hydrocephalus Shunts Market report:
The North America Hydrocephalus Shunts Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Hydrocephalus Shunts Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Hydrocephalus Shunts Market value chain can benefit from the information contained in a comprehensive market report.